Blog / Archives
Cruise Control Till Year End
Update 12/12 Or Maybe NOT!! Jobs data tomorrow and most funds will ride their positions through year end. In the meantime it is a traders market. Update next week but review all our portfolio...
Biotech Stocks Hit By Profit Taking-More Volatility Lies Ahead…Update-1
Bounce Back Day 12/2/14 FBT up 1.5% to $102.33 Biotech players realized that news about China, energy and holiday shopping data do not affect their stocks. Our large cap biopharma portfolio...
Rayno Life Science: Market Update 11/26… Stocks Cruise To New Highs
NASDAQ leads -up 0.6% to 4787 The October correction of ~7% was a "headfake" as macro events scared many investor away Technology and Healthcare Stocks Lead The Way The healthcare SPDR (XLV) is up...
Sierra SnowBlog: Nov. 26, 2014 Significant Storm on the Way…Update-1
Update 12/3 Much Needed Heavy Rain Comes To SoCal but Mammoth Gets Only~20 in Wet Snow Warm Weather Storm Hits The Coast The Mammoth snowman posted at 8 am and says the really big part of the storm...
Rayno Life Science Small Cap Picks: CLDX, PACB, FMI…Update-1
Update November 18 : NASDAQ 4702 up 0.67%, IBB at 295.25up 2.22% Recent Small Cap picks: CLDX 17.72 off 2.9% with profit taking.Very choppy trade. FCSC 2.67 flat little action, despite Press Release...
Rayno Life Science: Biotech Stocks Hit A Wall At New Highs Up 40% YTD
Red Tape Today Means Caution-Take Some Off XBI at $167.83 Off 2% Traders, investors, executives even pension funds are thrilled with biotech investing as the stock group rolls on to new highs this...
Rayno Life Science Stocks: Up 30%+ YTD After A Volatile October
Investors Whipsawed By V-Shaped Rally NASDAQ at New Highs 4631 DOW at New Highs 17,390 Investors got what was forecasted-a volatile October that moved from fear to greed in two weeks! The market was...
Sierra SnowBlog Oct. 2014: White Is the New Orange
Update 11/5/14 No storms on the horizon for next week in the West, but check out this model for a "polar express" in the East and Midwest also creating a "blocking pattern" for the West:...
Bio Investor Forum #2: T-Cell Therapies and Cancer Targets
Genetically Modified T-cells: Gene Therapy Is Back! Here are some quick notes and an overview of the companies at Bio: Immuno-Oncology is one of the hottest new areas of biopharmaceutical...
Rayno Life Science Performance: Up 21%+ YTD…FBT, GILD, ILMN
Biotechs Continue To Lead The Market NASDAQ registered its third day of gains up 2.38% for the period and life science stocks followed. The NAZ is now up 3.34% YTD. Biotech stocks are way ahead of...